Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Foon

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Advances in Hematology|April 27, 2012
Novel therapies for aggressive B-cell lymphomaKenneth A Foon, Kenichi Takeshita, Pier L Zinzani
Expert Opinion on Biological Therapy|January 9, 2003
Anti-idiotype antibody vaccine therapy for cancerMalaya Bhattacharya-Chatterjee, Sunil K Chatterjee, Kenneth A Foon
Current Protocols in Immunology|April 25, 2008
Carcinoembryonic antigen transgenic mouse models for immunotherapy and development of cancer vaccinesMalaya Bhattacharya-Chatterjee, Asim Saha, Kenneth A Foon, et al.
Immunology|August 10, 2006
Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigenAsim Saha, Sunil K Chatterjee, Kenneth A Foon, et al.
American Journal of Hematology|July 12, 2002
Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomasNitin Rohatgi, Renato V LaRocca, Vanessa Bard, et al.
International Journal of Cancer|November 28, 2008
Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic miceAsim Saha, Malaya Bhattacharya-Chatterjee, Kenneth A Foon, et al.
Journal of Leukocyte Biology|April 23, 2008
Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemiaJe-Jung Lee, Kenneth A Foon, Robbie B Mailliard, et al.
Leukemia Research|February 4, 2010
Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cellsMary T Litzinger, Kenneth A Foon, Kwong-Yok Tsang, et al.
Cancer Research|March 17, 2007
Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigenAsim Saha, Sunil K Chatterjee, Kenneth A Foon, et al.
Cancer Research|June 5, 2003
Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunityAsim Saha, Sunil K Chatterjee, Kenneth A Foon, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Advances in Hematology|April 27, 2012
Novel therapies for aggressive B-cell lymphomaKenneth A Foon, Kenichi Takeshita, Pier L Zinzani
Expert Opinion on Biological Therapy|January 9, 2003
Anti-idiotype antibody vaccine therapy for cancerMalaya Bhattacharya-Chatterjee, Sunil K Chatterjee, Kenneth A Foon
Current Protocols in Immunology|April 25, 2008
Carcinoembryonic antigen transgenic mouse models for immunotherapy and development of cancer vaccinesMalaya Bhattacharya-Chatterjee, Asim Saha, Kenneth A Foon, et al.
Immunology|August 10, 2006
Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigenAsim Saha, Sunil K Chatterjee, Kenneth A Foon, et al.
American Journal of Hematology|July 12, 2002
Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomasNitin Rohatgi, Renato V LaRocca, Vanessa Bard, et al.
International Journal of Cancer|November 28, 2008
Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic miceAsim Saha, Malaya Bhattacharya-Chatterjee, Kenneth A Foon, et al.
Journal of Leukocyte Biology|April 23, 2008
Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemiaJe-Jung Lee, Kenneth A Foon, Robbie B Mailliard, et al.
Leukemia Research|February 4, 2010
Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cellsMary T Litzinger, Kenneth A Foon, Kwong-Yok Tsang, et al.
Cancer Research|March 17, 2007
Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigenAsim Saha, Sunil K Chatterjee, Kenneth A Foon, et al.
Cancer Research|June 5, 2003
Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunityAsim Saha, Sunil K Chatterjee, Kenneth A Foon, et al.
Pageof 5